Fibromiyalji Sendromunda Klinik, Fizik Muayene ve Laboratuvar Değerlendirmeleri
Özet
Fibromiyalji Sendromu (FMS); kronik yaygın vücut ağrısı, yorgunluk, uyku bozukluğu ve bilişsel problemlerle karakterize, dünya genelinde %2-8 prevalansa sahip kronik bir klinik sendromdur. Kadınlarda ve yaşla birlikte görülme sıklığı artan bu hastalık, kas-iskelet sistemini etkileyen en yaygın üçüncü patolojidir. Tanı süreçleri geçmişten günümüze 1990 ACR kriterlerindeki 18 hassas noktanın muayenesinden, semptom ağırlıklı ve hasta sorgulama anketlerine dayalı 2010 modifikasyonlarına doğru evrilmiştir. FMS'nin etyopatogenezinde genetik yatkınlık, stres, santral sensitizasyon ve küçük lif nöropatisi gibi nöropatik mekanizmalar rol oynamaktadır. Hastalarda dinlendirmeyen uyku (alfa-delta uykusu anomalisi), sabah tutukluğu, kognitif disfonksiyon (fibrofog), parestezi, denge bozuklukları ile depresyon ve anksiyete gibi psikiyatrik komorbiditeler sıkça gözlenir. Laboratuvar ve radyolojik tetkiklerin yeri kısıtlı olup temel amaç ayırıcı tanıdır; ancak BOS'ta substans P artışı ve serumda proinflamatuar IL-8 yüksekliği gibi biyobelirteçler patogenezi desteklemektedir. Tedavi, hastalığın çok bileşenli yapısı nedeniyle bireysel ve çok yönlü bir yaklaşım gerektirmektedir.
Fibromyalgia Syndrome (FMS) is a chronic clinical syndrome characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, and cognitive dysfunction, affecting 2-8% of the global population. More prevalent in women and older age groups, it constitutes the third most common musculoskeletal disorder. Diagnostic strategies have transitioned from evaluating 18 tender points under the 1990 ACR criteria to utilizing symptom-severity scales and patient questionnaires introduced in the 2010 modifications. The complex pathogenesis involves genetic predisposition, psychological stress, central sensitization, and small-fiber polyneuropathy. Key clinical manifestations include non-restorative sleep (alpha-delta sleep anomaly), morning stiffness, cognitive impairment (fibrofog), paresthesia, and balance issues, frequently accompanied by psychiatric comorbidities like depression and anxiety. While laboratory and imaging findings remain limited and primarily serve to exclude differential diagnoses, elevated levels of Substance P in cerebrospinal fluid and pro-inflammatory IL-8 in serum provide crucial biological insights. Consequently, the multifaceted nature of FMS necessitates highly individualized, multidimensional therapeutic interventions.
Referanslar
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1990;33(2):160-72.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis care & research. 2010;62(5):600-10.
Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC musculoskeletal disorders. 2007;8(1):1-11.
Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, et al. The German fibromyalgia consumer reports–a cross-sectional survey. BMC Musculoskeletal Disorders. 2012;13(1):1-6.
Bennett RM. Clinical manifestations and diagnosis of fibromyalgia. Rheumatic diseases clinics of North America. 2009;35(2):215-32.
D. E. Fibromiyalji Sendromu Nöropatik Ağrı mıdır? Turkiye Klinikleri J PM&R-Special Topics 2015;.
Martinez-Lavin M. Fibromyalgia is a neuropathic pain syndrome. The Journal of rheumatology. 2006;33(4):827-8.
Giske L, Bautz-Holter E, Sandvik L, Røe C. Relationship between pain and neuropathic symptoms in chronic musculoskeletal pain. Pain Medicine. 2009;10(5):910-7.
Koroschetz J, Rehm SE, Gockel U, Brosz M, Freynhagen R, Tölle TR, et al. Fibromyalgia and neuropathic pain-differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC neurology. 2011;11(1):1-8.
Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. PAIN®. 2013;154(11):2310-6.
Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, et al. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. Journal of the neurological sciences. 2014;347(1-2):143-7.
Kasper S. The psychiatrist confronted with a fibromyalgia patient. Human Psychopharmacology: Clinical and Experimental. 2009;24(S1):S25-S30.
Bennett RM. Clinical manifestations and diagnosis of fibromyalgia. Rheumatic Disease Clinics. 2009;35(2):215-32.
Wessely S. Chronic fatigue: symptom and syndrome. Annals of internal medicine. 2001;134(9_Part_2):838-43.
Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain medicine. 2007;8(suppl_2):S63-S74.
Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological review. 1998;105(1):83.
Moldofsky H. The significance of the sleeping–waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine. 2008;75(4):397-402.
Cetin N, Yalbuzdag SA, Cabioglu MT, Turhan N. Factors affecting the quality of life in patients with fibromyalgia/Fibromiyalji sendromunda yasam kalitesi uzerine etkili faktorler. Turkish Journal of Rheumatology. 2009:77-82.
Wolfe F, Hassett AL, Walitt B, Michaud K. Mortality in fibromyalgia: An 8,186 patient study over 35 years. Arthritis care and research (2010). 2011;63(1):94-101.
Stehlik R, Arvidsson L, Ulfberg J. Restless legs syndrome is common among female patients with fibromyalgia. European neurology. 2009;61(2):107-11.
Germanowicz D, Lumertz MS, Martinez D, Margarites AF. Sleep disordered breathing concomitant with fibromyalgia syndrome. Jornal Brasileiro de Pneumologia. 2006;32(4):333-8.
Smythe HA, Moldofsky H. Two contributions to understanding of the" fibrositis" syndrome. Bulletin on the rheumatic diseases. 1977;28(1):928-31.
Sann H, Pierau F-K. Efferent functions of C-fiber nociceptors. Zeitschrift für Rheumatologie. 1998;57(2):S8-S13.
Littlejohn G, Weinstein C, Helme R. Increased neurogenic inflammation in fibrositis syndrome. The Journal of rheumatology. 1987;14(5):1022-5.
Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, et al. Fibromyalgia syndrome. The Journal of rheumatology. 2005;32(11):2270-7.
Munguía-Izquierdo D, Legaz-Arrese A, Moliner-Urdiales D, Reverter-Masía J. [Neuropsychological performance in patients with fibromyalgia syndrome: relation to pain and anxiety]. Psicothema. 2008;20(3):427-31.
Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. The Journal of rheumatology Supplement. 2005;75:6-21.
Jin H, Patil PM, Sharma A. Topical review: the enigma of fibromyalgia. J Oral Facial Pain Headache. 2014;28(2):107-18.
Glass JM. Fibromyalgia and cognition. Journal of Clinical Psychiatry. 2008;69(supplement 2):20-4.
Grisart J, Linden M, Masquelier E. Controlled processes and automaticity in memory functioning in fibromyalgia patients: Relation with emotional stress and hypervigilance. Journal of clinical and experimental neuropsychology. 2002;24(8):994-1009.
Suhr JA. Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. Journal of psychosomatic research. 2003;55(4):321-9.
Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy. The Journal of Rheumatology. 2008;35(7):1371-7.
Parkin AJ. Human memory: the hippocampus is the key. Current Biology. 1996;6(12):1583-5.
Tischler L, Brand SR, Stavitsky K, Labinsky E, Newmark R, Grossman R, et al. The relationship between hippocampal volume and declarative memory in a population of combat veterans with and without PTSD. Annals of the New York Academy of Sciences. 2006;1071(1):405-9.
McEwen BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Annals of the New York Academy of Sciences. 2001;933(1):265-77.
Leavitt F, Katz RS, Mills M, Heard AR. Cognitive and dissociative manifestations in fibromyalgia. JCR: Journal of Clinical Rheumatology. 2002;8(2):77-84.
Lutz J, Jäger L, de Quervain D, Krauseneck T, Padberg F, Wichnalek M, et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: A diffusion‐tensor and volumetric imaging study. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2008;58(12):3960-9.
Martinez-Lavin M. Fibromyalgia as a sympathetically maintained pain syndrome. Current pain and headache reports. 2004;8(5):385-9.
Wiffen PJ, Derry S, Moore RA, Aldington D, Cole P, Rice AS, et al. Antiepileptic drugs for neuropathic pain and fibromyalgia‐an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2013(11).
Eyigör S, Kirazli Y. Fibromyalgia syndrome from the perspective of neuropathic pain. Agri: Agri (Algoloji) Dernegi'nin Yayin organidir= The journal of the Turkish Society of Algology. 2008;20(1):8-12.
Nichols DS, Glenn TM, Hutchinson KJ. Changes in the mean center of balance during balance testing in young adults. Physical therapy. 1995;75(8):699-706.
Meireles SA, Antero DC, Kulczycki MM, Skare TL. Prevalence of falls in fibromyalgia patients. Acta ortopedica brasileira. 2014;22:163-6.
Jones KD, Horak FB, Winters KS, Morea JM, Bennett RM. Fibromyalgia is associated with impaired balance and falls. Journal of clinical rheumatology: practical reports on rheumatic & musculoskeletal diseases. 2009;15(1):16.
Leveille SG, Bean J, Bandeen‐Roche K, Jones R, Hochberg M, Guralnik JM. Musculoskeletal pain and risk for falls in older disabled women living in the community. Journal of the American Geriatrics Society. 2002;50(4):671-8.
Orr R. Contribution of muscle weakness to postural instability in the elderly. Eur J Phys Rehabil Med. 2010;46(2):183-220.
Power K, Behm D, Cahill F, Carroll M, Young W. An acute bout of static stretching: effects on force and jumping performance. Medicine & Science in Sports & Exercise. 2004;36(8):1389-96.
Fietta P, Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomedica-Ateneo Parmense. 2007;78(2):88.
Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain. 2006;124(1-2):117-25.
Carter LE, McNeil DW, Vowles KE, Sorrell JT, Turk CL, Ries BJ, et al. Effects of emotion on pain reports, tolerance and physiology. Pain Research and Management. 2002;7(1):21-30.
Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. The American journal of psychiatry. 1991;148(12):1721-6.
Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis & Rheumatism. 2004;50(3):944-52.
Mcdowell CP, Cook DB, Herring MP. The effects of exercise training on anxiety in fibromyalgia patients: a meta-analysis. Med Sci Sports Exerc. 2017;49(9):1868-76.
Celiker R, Borman P, Öktem F, Gökçe-Kutsal Y, Başgöze O. Psychological disturbance in fibromyalgia: relation to pain severity. Clinical rheumatology. 1997;16(2):179-84.
Yunus MB, editor Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Seminars in arthritis and rheumatism; 2008: Elsevier.
Goldenberg D. Fibromyalgia and related syndrome. Rheumatology. 2003:701-12.
Yılmaz S, Erdem H. Clinical and laboratory findings in fibromyalgia syndrome. Turkiye Klinikleri J Immunol Rheumatol-Special Topics. 2009;2:9-15.
Russell IJ, Raphael KG. Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. CNS spectrums. 2008;13(S5):6-11.
Yunus M, Dailey J, Aldag J, Masi A, Jobe P. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. The Journal of rheumatology. 1992;19(1):90-4.
Evengard B, Nilsson C, Lindh G, Lindquist L, Eneroth P, Fredrikson S, et al. Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain. 1998;78(2):153-5.
Ciregia F, Giacomelli C, Giusti L, Lucacchini A, Bazzichi L. Diagnosis of fibromialgia syndrome: potential biomarkers and proteomic approach: Intech; 2011.
Wallace D, Linker‐Israeli M, Hallegua D, Silverman S, Silver D, Weisman M. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology. 2001;40(7):743-9.
